SUNPHARMA does a dead cat bounce, it's still too early to buy into it
18 May, 20265 min read
SUNPHARMA delivered good returns today. On a longer term basis, investors in SUN PHARMACEUTICAL IND L made -0.02% per day. Monday's performance of +1.47% was a significant outperformance compared to it's daily average.